Mark Bagarazzi

Safety, efficacy, and immunogenicity of VGX-3100, a therapeutic synthetic DNA vaccine targeting human papillomavirus 16 and 18 E6 and E7 proteins for cervical intraepithelial…

The Lancet · 2015 · Last of 24 authors · 571 citations

First human trial of a DNA-based vaccine for treatment of human immunodeficiency virus type 1 infection: safety and host response

The Journal of Infectious Diseases · 1998 · 498 citations